Author Question: The nurse is teaching a patient who takes warfarin (Coumadin) about a coagulation monitoring device. ... (Read 49 times)

tfester

  • Hero Member
  • *****
  • Posts: 534
The nurse is teaching a patient who takes warfarin (Coumadin) about a coagulation monitoring device. Which blood clotting time should the device monitors?
 
  a. PT
  b. PTT
  c. INR
  d. ACT

Question 2

The nurse reviewing laboratory reports for a patient admitted for acute pyelenophritis. Which finding is most concerning to the nurse?
 
  a. Blood urea nitrogen (BUN) of 10.5 mg/dL
  b. Sodium of 140 mEq/L
  c. Potassium of 5.0 mEq/L
  d. Creatinine of 2.0 mg/dL



kusterl

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

C
A coagulation monitoring device measures the INR level for clotting time for a person on thera-peutic doses of warfarin.

Answer to Question 2

D
A creatinine of 2.0 is abnormally high and indicates that kidney function negatively affected. The BUN, sodium, and potassium values are within normal limits. (Laboratory ranges include: BUN 10 to 20 mg/dL, creatinine 0.6 to 1.2 mg/dL, sodium 135 to 145 mEq/L, and potassium 3.5 to 5.5 mEq/L.)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Studies show that systolic blood pressure can be significantly lowered by taking statins. In fact, the higher the patient's baseline blood pressure, the greater the effect of statins on his or her blood pressure.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library